Should I buy or sell R1 RCM stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RCM shares. View RCM analyst ratings or view top-rated stocks .

What is R1 RCM's stock price target for 2024?

13 equities research analysts have issued 12-month price targets for R1 RCM's shares. Their RCM share price targets range from $11.00 to $22.00. On average, they anticipate the company's share price to reach $16.87 in the next year. This suggests a possible upside of 40.0% from the stock's current price. View analysts price targets for RCM or view top-rated stocks among Wall Street analysts .

How have RCM shares performed in 2024?

R1 RCM's stock was trading at $10.57 at the beginning of the year. Since then, RCM stock has increased by 14.0% and is now trading at $12.05. View the best growth stocks for 2024 here .

When is R1 RCM's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our RCM earnings forecast .

How can I listen to R1 RCM's earnings call?

R1 RCM will be holding an earnings conference call on Wednesday, May 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link .

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) released its earnings results on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a net margin of 0.15% and a trailing twelve-month return on equity of 0.12%. R1 RCM's quarterly revenue was up 33.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.11 EPS.

What ETFs hold R1 RCM's stock?

ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC) , Fidelity Digital Health ETF (FDHT) and SPDR S&P Health Care Services ETF (XHS) . iShares U.S. Healthcare Providers ETF (IHF) .

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion.

What is Joseph Flanagan's approval rating as R1 RCM's CEO?

253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com . Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA) , JD.com (JD) , Baozun (BZUN) , Inseego (INSG) , BioXcel Therapeutics (BTAI) , Marvell Technology (MRVL) , Akoustis Technologies (AKTS) , Alibaba Group (BABA) , Bilibili (BILI) and Model N (MODN) .

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by many different retail and institutional investors. Top institutional investors include Oak Thistle LLC (0.00%) and Cannon Global Investment Management LLC (0.00%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl , John B Henneman III , John M Sparby , Joseph Gerard Flanagan , Lee Rivas and Richard B Jr Evans . View institutional ownership trends .

How do I buy shares of R1 RCM?

Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does R1 RCM have any subsidiaries?

The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC. Read More

NASDAQ:RCM

R1 RCM (RCM) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free RCM Stock Alerts

$12.05

-0.10 (-0.82%)

(As of 03:21 PM ET)

Compare

Today's Range: $12.01
▼
$12.20
50-Day Range: $10.45
▼
$14.58
52-Week Range: $8.87
▼
$18.70

Volume: 976,090 shs
Average Volume: 3.77 million shs
Market Capitalization: $5.07 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.87

Get R1 RCM alerts:

R1 RCM MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.62 Rating Score
Upside/Downside: 40.0% Upside
$16.87 Price Target
Short Interest: Healthy
7.95% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.33
Upright™ Environmental Score
News Sentiment: 0.34
Based on 3 Articles This Week
Insider Trading: Selling Shares
$143,959 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.05) to $0.15 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.53 out of 5 stars

Business Services Sector

29th out of 299 stocks

Management Services Industry

1st out of 5 stocks

4.3

Analyst's Opinion

Consensus Rating
R1 RCM has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.
Amount of Analyst Coverage
R1 RCM has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
7.95% of the float of R1 RCM has been sold short.
Short Interest Ratio / Days to Cover
R1 RCM has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in R1 RCM has recently decreased by 3.86%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
R1 RCM does not currently pay a dividend.
Dividend Growth
R1 RCM does not have a long track record of dividend growth.

3.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
R1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.
Environmental Sustainability
The Environmental Impact score for R1 RCM is -1.33.

1.3

News and Social Media Coverage

News Sentiment
R1 RCM has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for R1 RCM this week, compared to 5 articles on an average week.
Search Interest
Only 3 people have searched for RCM on MarketBeat in the last 30 days. This is a decrease of -79% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is a decrease of -55% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, R1 RCM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $143,959.00 in company stock.
Percentage Held by Insiders
37.00% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for R1 RCM are expected to grow in the coming year, from ($0.05) to $0.15 per share.
Price to Book Value per Share Ratio
R1 RCM has a P/B Ratio of 1.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About R1 RCM Stock (NASDAQ:RCM)

R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.

RCM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RCM Stock News Headlines

April 18, 2024 | bbc.co.uk

Sit Down Stand Up Olympian Special

April 12, 2024 | americanbankingnews.com

R1 RCM (NASDAQ:RCM) Rating Reiterated by KeyCorp

April 18, 2024 | Crypto 101 Media (Ad)

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

April 11, 2024 | americanbankingnews.com

R1 RCM (NASDAQ:RCM) Receives Overweight Rating from Cantor Fitzgerald

April 10, 2024 | americanbankingnews.com

R1 RCM Inc. (NASDAQ:RCM) Given Average Rating of "Moderate Buy" by Brokerages

April 9, 2024 | fxstreet.com

EUR/USD holds above 1.0860, eyes on US CPI, ECB rate decision

April 8, 2024 | axios.com

Vista takes Model N private for $1.25B

April 4, 2024 | finance.yahoo.com

Inbox Health Announces Appointment of Kent Ivanoff to Board of Directors

April 18, 2024 | Crypto 101 Media (Ad)

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

April 3, 2024 | finance.yahoo.com

Capstreet-backed Surgical Notes Names Dominic Brignola as Chief Financial Officer

April 1, 2024 | globenewswire.com

R1 RCM to Release First Quarter 2024 Results on May 8, 2024

April 1, 2024 | markets.businessinsider.com

Truist Financial Reaffirms Their Hold Rating on R1 RCM (RCM)

March 27, 2024 | globenewswire.com

R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report

March 20, 2024 | markets.businessinsider.com

Buy Rating Affirmed for R1 RCM Amid Strong Fundamentals and Prospective Acquisition

March 20, 2024 | msn.com

R1 RCM pushes sales process forward, hiring bankers

March 20, 2024 | msn.com

R1 RCM gains amid Citi upgrade as deal still likely to happen

March 20, 2024 | markets.businessinsider.com

Analyst Scoreboard: 12 Ratings For R1 RCM

March 19, 2024 | wsj.com

R1 RCM Tells Two Top Holders to End Buyout Talks

March 19, 2024 | msn.com

R1 RCM demands that New Mountain Capital & TCP-ASC talks must cease

March 15, 2024 | finance.yahoo.com

RCM Apr 2024 20.000 call

March 12, 2024 | markets.businessinsider.com

Hold Rating on R1 RCM Amid Acquisition Talks and Valuation Considerations

March 11, 2024 | markets.businessinsider.com

R1 RCM Announces Formation Of Special Committee To Evaluate Strategic Alternatives

March 11, 2024 | msn.com

R1 RCM forms special committee to evaluate options after New Mountain's offer

March 11, 2024 | markets.businessinsider.com

R1 RCM Poised for Growth: Outperform Rating and $17 Target Justified by Strong LBO Potential and Historical Multiples

March 11, 2024 | marketwatch.com

R1 RCM to Explore Strategic Options After New Mountain Approach

March 11, 2024 | finance.yahoo.com

R1 RCM Forms Special Committee to Evaluate Strategic Alternatives

March 6, 2024 | msn.com

Truist Securities Downgrades R1 RCM (RCM)

See More Headlines

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/16/2023
Today: 4/18/2024
Next Earnings (Confirmed): 5/08/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Business Services
Industry: Management services
Sub-Industry: Health Care Services
Current Symbol: NASDAQ:RCM
Previous Symbol: NYSE:RCM
CUSIP: 00438V10
CIK: 1472595
Web: www.r1rcm.com
Phone: (312) 324-7820
Fax: 302-655-5049
Employees: 30,000
Year Founded: 2003

Price Target and Rating

Average Stock Price Target: $16.87
High Stock Price Target: $22.00
Low Stock Price Target: $11.00
Potential Upside/Downside: +38.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.62
Research Coverage: 13 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $3.30 million
Net Margins: 0.15%
Pretax Margin: 0.93%
Return on Equity: 0.12%
Return on Assets: 0.07%

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 1.83
Quick Ratio: 1.83

Sales & Book Value

Annual Sales: $2.25 billion
Price / Sales: 2.27
Cash Flow: $0.68 per share
Price / Cash Flow: 17.82
Book Value: $6.56 per share
Price / Book: 1.86

Miscellaneous

Outstanding Shares: 420,730,000
Free Float: 265,060,000
Market Cap: $5.12 billion
Optionable: Optionable
Beta: 0.78

Social Links

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Lee Rivas (Age 49)
CEO & Director
Comp: $1.12M
Mr. John M. Sparby (Age 48)
President
Comp: $656.99k
Ms. Jennifer Williams (Age 47)
Executive VP, CFO & Treasurer
Ms. Pamela L. Spikner (Age 47)
Principal Accounting Officer & Chief Accounting Officer
Evan Smith C.F.A.
Senior Vice President of Finance & Investor Relations
Mr. Corey Perman
Executive Vice President of Compliance & Risk
Mr. Sean Radcliffe
Executive VP, General Counsel & Corporate Secretary
Ms. Kate Sanderson
Executive VP & Chief Human Resources Officer
Mr. David Strickle
Executive Vice President of Integration
Mr. Kyle A. Hicok (Age 44)
Executive VP & Chief Commercial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RCM Stock Analysis - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?: 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RCM shares.
View RCM analyst ratings or view top-rated stocks.
What is R1 RCM's stock price target for 2024?: 13 equities research analysts have issued 12-month price targets for R1 RCM's shares. Their RCM share price targets range from $11.00 to $22.00. On average, they anticipate the company's share price to reach $16.87 in the next year. This suggests a possible upside of 40.0% from the stock's current price.
View analysts price targets for RCM or view top-rated stocks among Wall Street analysts.
How have RCM shares performed in 2024?: R1 RCM's stock was trading at $10.57 at the beginning of the year. Since then, RCM stock has increased by 14.0% and is now trading at $12.05.
View the best growth stocks for 2024 here.
When is R1 RCM's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our RCM earnings forecast.
How can I listen to R1 RCM's earnings call?: R1 RCM will be holding an earnings conference call on Wednesday, May 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.
How were R1 RCM's earnings last quarter?: R1 RCM Inc. (NASDAQ:RCM) released its earnings results on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a net margin of 0.15% and a trailing twelve-month return on equity of 0.12%. R1 RCM's quarterly revenue was up 33.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.11 EPS.
What ETFs hold R1 RCM's stock?: ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT) and SPDR S&P Health Care Services ETF (XHS).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has R1 RCM issued on next quarter's earnings?: R1 RCM issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion.
What is Joseph Flanagan's approval rating as R1 RCM's CEO?: 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.
What other stocks do shareholders of R1 RCM own?: Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).
Who are R1 RCM's major shareholders?: R1 RCM's stock is owned by many different retail and institutional investors. Top institutional investors include Oak Thistle LLC (0.00%) and Cannon Global Investment Management LLC (0.00%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, John B Henneman III, John M Sparby, Joseph Gerard Flanagan, Lee Rivas and Richard B Jr Evans.
View institutional ownership trends.
How do I buy shares of R1 RCM?: Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does R1 RCM have any subsidiaries?: The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More

This page (NASDAQ:RCM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial